PKG00283473.docx

This is an application submission document for a Centers for Disease Control and Prevention (CDC) cooperative agreement opportunity focused on injury prevention and control research and state and community-based programs (CFDA 93.136, RFA-GH-18-000). The application deadline is September 30, 2030. Eligible applicants include U.S. state governments, territorial governments, local governments, and their bona fide agents, with only one application funded per state or territory. Applicants must have access to state or territory-wide data sources. The funding instrument is a cooperative agreement with a 12-month initial budget period and potential performance period of up to five years, subject to fund availability and satisfactory progress. Typical award amounts historically range from $100,000 to $700,000 annually.

The application will undergo a two-phase review process. Phase I evaluates eligibility and completeness; Phase II assesses approach, evaluation and performance measurement, and organizational capacity to implement the proposed strategy. Applicants will be notified within 30 days if their application does not meet eligibility or submission requirements. Following approval, a Notice of Award will be issued indicating funding for the first budget period and recommended support for the remainder of the project period. Recipients must maintain records for three years beyond the award period, subject to audit by DHHS and other federal officials. Non-competitive continuation funding may be available for subsequent budget periods contingent upon satisfactory progress and federal government interest.